Keyphrases
Casein Kinase 2
100%
Leukemia
77%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
48%
High Risk
43%
Tumor Suppressor
38%
Transcriptional Regulation
38%
GATA1
34%
Erythroid Differentiation
34%
Associated Genes
34%
Gene Expression
31%
Cell Proliferation
30%
Tumor Suppressor Activity
29%
Acute Lymphoblastic Leukemia
26%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
24%
Therapeutic Efficacy
23%
Signaling Regulation
23%
CX-4945
22%
IKZF1
19%
Gene Transcription
18%
Hematological Malignancies
16%
Overexpression
16%
Bcl-xL
15%
Epigenetic Gene Regulation
15%
Protein Kinase CK2
15%
Signaling Pathway
15%
Histone Deacetylase 1 (HDAC1)
15%
Transcription Factor
15%
Gene Regulation
14%
Phosphorylation
13%
Therapeutic Target
13%
Cell Apoptosis
13%
Novel Therapeutics
13%
Hematopoietic Cells
13%
Megakaryocytic
13%
Protein Stability
13%
Acetylation
12%
Protein Phosphatase
12%
Acute Myeloid Leukemia
12%
K562 Cells
11%
Universal Primers
11%
Myeloid Cell Lines
11%
Cellular Signaling
11%
Chemosensitivity
11%
DNA Genotyping
11%
Erythroid
11%
Glycogen Synthase Kinase 3 (GSK3)
11%
Nucleophosmin 1 (NPM1)
11%
JARID1B
11%
P300
11%
Protein Regulation
11%
Biochemistry, Genetics and Molecular Biology
Casein Kinase
57%
B Cell
46%
Gene Expression
42%
Tumor Suppressor Protein
35%
Casein Kinase 2
23%
GATA1
23%
Transcription
22%
Promoter Region
20%
T Cell
17%
Epigenetics
17%
Programmed Cell Death
14%
HDAC1
14%
Cell Proliferation
13%
Downregulation
13%
Phosphotransferase
12%
Kinase
12%
Acetylation
12%
Myristic Acid
12%
Phosphoinositide 3-Kinase
12%
Histone
11%
JARID1B
11%
Hepatitis B Virus
11%
Demethylase
11%
Protein Stability
11%
NPM1
11%
Genotyping
11%
Enhancer Region
11%
Glycogen Synthase Kinase 3
11%
Chemosensitivity
11%
Small GTPase
11%
PIKFYVE
11%
K562 Cells
9%
Protein Phosphatase 1
9%
Chromatin Remodeling
9%
IKZF1
8%
DNA Binding
8%
Pribnow Box
5%
Pharmacology, Toxicology and Pharmaceutical Science
Casein Kinase
74%
Leukemia
66%
Casein Kinase II
63%
Acute Lymphoblastic Leukemia
59%
Tumor Suppressor Protein
40%
Transcription Factor GATA 1
23%
Combination Therapy
23%
Histone Deacetylase 1
14%
Acute Myeloid Leukemia
13%
Silmitasertib
13%
Hepatitis B Virus
11%
Glycogen Synthase Kinase 3
11%
12-O-Tetradecanoylphorbol-13-Acetate
11%
Histone Demethylase
11%
Virus DNA
11%
Nucleophosmin
11%
Phosphatidylinositol 3 Kinase
9%
Phosphoprotein Phosphatase 1
9%
Therapeutic Effect
6%
Doxorubicin
6%
Phosphotransferase
5%
Diseases
5%
